Patents by Inventor Qing Ye

Qing Ye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optical fibers having a surface light field emulation (-LiFE) segment and method of making the same
    Patent number: 8331750
    Abstract: A modified optical fiber comprises one Surface Light Field Emulation (s-LiFE) segment, comprising a core; a cladding; and multiple controlled nanoscale diffusion centers to emit light through the side of the optical fibers. Optionally, the modified optical fiber has a coating. The nanoscale diffusion centers are physical geometric patterns or composition patterns in the cladding or the coating. The s-LiFE optical fiber is a member of an illumination system further comprising a light source. The method of making of said s-LiFE optical fiber comprises a fiber spooning step.
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: December 11, 2012
    Inventors: Kung-Li Deng, Daniel Robert Olson, Qing Ye
  • METHOD FOR PROTECTING A CONVERTER AND A CONVERTER IMPLEMENTING THE METHOD
    Publication number: 20120294053
    Abstract: A method for protecting a converter device comprises the steps of: detecting an alternating current signal; when the alternating current signal is abnormal, generating an activating signal according to the abnormal alternating current signal; generating a control signal according to the activating signal; and controlling at least one synchronous rectifying power switch of the converter device according to the control signal. Furthermore, a converter device which implements the method is provided.
    Type: Application
    Filed: September 23, 2011
    Publication date: November 22, 2012
    Applicant: DELTA ELECTRONICS (SHANGHAI) CO., LTD.
    Inventors: Chao Yan, Yi-Qing YE, Chong-Feng ZHENG, Jian-Ping YING
  • COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2
    Publication number: 20120214807
    Abstract: The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.
    Type: Application
    Filed: October 26, 2011
    Publication date: August 23, 2012
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Shomir Ghosh, Prakash Raman, Kevin Sprott, Amy M. Elder, Sian Griffiths, Francois Soucy, Qing Ye
  • COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2
    Publication number: 20120208818
    Abstract: The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.
    Type: Application
    Filed: October 10, 2011
    Publication date: August 16, 2012
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Amy M. Elder, Shomir Ghosh, Sian Griffiths, Prakash Raman, Francois Soucy, Kevin Sprott, Qing Ye
  • Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
    Patent number: 8168788
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer or osteolytic bone disorders.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: May 1, 2012
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Kenneth G. Carson, Shomir Ghosh, Prakash Raman, Francois Soucy, Qing Ye
  • Polymer comprising phenyl pyridine units
    Patent number: 8163402
    Abstract: The invention relates to a polymer comprising structural unit of formula I: wherein R1, R2, R3, R4, R5, and R6 are independently at each occurrence a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; a, b, d, e and f are independently at each occurrence 0, or an integer ranging from 1 to 4; c is independently at each occurrence 0, or an integer ranging from 1 to 3. In another aspect, the invention relates to monomers for preparing the polymers. In yet another aspect, the invention relates to an optical electronic device comprising a polymer comprising structural unit of formula I.
    Type: Grant
    Filed: December 6, 2008
    Date of Patent: April 24, 2012
    Assignee: General Electric Company
    Inventors: Qing Ye, Jie Liu, Yangang Liang, Shengxia Liu
  • Method of fabrication of cubic boron nitride conical microstructures
    Patent number: 8158011
    Abstract: A conical structure of cubic Boron Nitride (cBN) is formed on a diamond layered substrate. A method of forming the cBN structure includes steps of (a) forming diamond nuclei on a substrate, (b) growing a layer of diamond film on the substrate, (c) depositing a cBN film on said diamond layer, (d) pre-depositing nanoscale etching masks on the cBN film, and (e) etching the deposited cBN film. In particular, though not exclusively, the cubic Boron Nitride structure has great potential applications in probe analytical and testing techniques including scanning probe microscopy (SPM) and nanoindentation, nanomechanics and nanomachining in progressing microelectromechanical system (MEMS) and nanoelectyromechanical system (NEMS) devices, field electron emission, vacuum microelectronic devices, sensors and different electrode systems including those used in electrochemistry.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: April 17, 2012
    Assignee: City University of Hong Kong
    Inventors: Wen-Jun Zhang, Igor Bello, Shuit-Tong Lee, You-Sheng Zou, Yat Ming Chong, Qing Ye
  • Electron-transporting polymers
    Patent number: 8101699
    Abstract: The invention relates to polymers useful in optoelectronic devices and comprising structural unit of formula I: wherein R1 and R2 are independently at each occurrence, hydrogen, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; R3 is H or alkyl; a and b are, independently at each occurrence 0, or an integer ranging from 1 to 3; and Ar is a direct bond or aryl.
    Type: Grant
    Filed: December 2, 2008
    Date of Patent: January 24, 2012
    Assignee: General Electric Company
    Inventors: Qing Ye, Jie Liu, James Anthony Cella, Eisaku Katoh
  • Compounds useful as antagonists of CCR2
    Patent number: 8067415
    Abstract: The present invention provides compounds of general formula (I) or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: November 29, 2011
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Amy M. Elder, Shomir Ghosh, Sian Griffiths, Prakash Raman, Francois Soucy, Kevin Sprott, Qing Ye
  • Compounds useful as antagonists of CCR2
    Patent number: 8067457
    Abstract: The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.
    Type: Grant
    Filed: October 26, 2006
    Date of Patent: November 29, 2011
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Shomir Ghosh, Prakash Raman, Kevin Sprott, Amy M. Elder, Sian Griffiths, Francois Soucy, Qing Ye
  • Compound comprising phenyl pyridine units
    Patent number: 8062768
    Abstract: Organic compounds of formula I may be used in optoelectronic devices wherein R1 is, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; R2 is, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; a is, independently at each occurrence, an integer ranging from 0-4; b is, independently at each occurrence, an integer ranging from 0-3; Ar1 is a direct bond or heteroaryl, aryl, or alkyl or cycloalkyl; Ar2 is heteroaryl, aryl, or alkyl or cycloalkyl; c is 0, 1 or 2; and n is an integer ranging from 2-4.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: November 22, 2011
    Assignee: General Electric Company
    Inventors: Yangang Liang, Shengxia Liu, Kelly Scott Chichak, Qing Ye, Jie Liu
  • Compound comprising phenyl pyridine units
    Patent number: 8053095
    Abstract: Compounds of formula I may be used in optoelectronic devices wherein R1 is, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; a is, independently at each occurrence, an integer ranging from 0-4; b is 0, 1 or 2; Ar1 is a direct bond or heteroaryl, aryl, or alkyl or cycloalkyl; Ar2 is heteroaryl, aryl, or alkyl or cycloalkyl; c is an integer ranging from 1-7; and n is an integer ranging from 2-4.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: November 8, 2011
    Assignee: General Electric Company
    Inventors: Qing Ye, Jie Liu
  • Inkjet printing correction method and inkjet printing apparatus
    Patent number: 8047627
    Abstract: An inkjet printing correction method is used with an inkjet printing apparatus. The inkjet printing correction method includes the following steps. Firstly, a first test image file is printed out as a print test pattern by the inkjet printing apparatus. Then, the print test pattern is scanned to obtain a second test image file. Then, all second block intervals are compared with respective first block intervals, thereby obtaining correction interval difference data. According to the comparing results, a procedure of ejecting ink droplets from the ink nozzles is determined to be advanced or delayed.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: November 1, 2011
    Assignee: Primax Electronics Ltd.
    Inventor: Xiang-Qing Ye
  • Compound comprising phenyl pyridine units
    Patent number: 8039125
    Abstract: Organic compounds of formula I may be used in optoelectronic devices wherein R1 is, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; R2 is, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; a is, independently at each occurrence, an integer ranging from 0-4; b is, independently at each occurrence, an integer ranging from 0-3; Ar1 is a direct bond or heteroaryl, aryl, or alkyl or cycloalkyl; Ar2 is heteroaryl, aryl, or alkyl or cycloalkyl; c is 0, 1 or 2; and n is an integer ranging from 2-4.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: October 18, 2011
    Assignee: General Electric Company
    Inventors: Qing Ye, Yangang Liang, Shengxia Liu, Kelly Scott Chichak, Jie Liu
  • Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
    Publication number: 20110237601
    Abstract: The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula I are provided: or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer or osteolytic bone disorders.
    Type: Application
    Filed: December 17, 2010
    Publication date: September 29, 2011
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Kenneth G. Carson, Prakash Raman, Francois Soucy, Qing Ye, Shomir Ghosh
  • COMPOUND COMPRISING PHENYL PYRIDINE UNITS
    Publication number: 20110207877
    Abstract: Polymers comprising structural units derived from compounds of formula I may be used in optoelectronic devices (formula should be inserted here) wherein R1 is independently at each occurrence a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; and a is independently at each occurrence 0, or an integer ranging from 1 to 4.
    Type: Application
    Filed: July 9, 2009
    Publication date: August 25, 2011
    Inventors: Qing Ye, Jie Liu
  • CHEMICAL COMPOUNDS
    Publication number: 20110190272
    Abstract: The invention relates to chemical compounds of formula (I): or pharmaceutically acceptable salts thereof which possess CSF-IR kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.
    Type: Application
    Filed: May 6, 2009
    Publication date: August 4, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Kevin Daly, Del Valle David, David Scott, Qing Ye
  • Optical fibers having a Surface Light Field Emulation (s-LiFE) segment and method of making the same
    Publication number: 20110188261
    Abstract: A modified optical fiber comprises one Surface Light Field Emulation (s-LiFE) segment, comprising a core; a cladding; and multiple controlled nanoscale diffusion centers to emit light through the side of the optical fibers. Optionally, the modified optical fiber has a coating. The nanoscale diffusion centers are physical geometric patterns or composition patterns in the cladding or the coating. The s-LiFE optical fiber is a member of an illumination system further comprising a light source. The method of making of said s-LiFE optical fiber comprises a fiber spooning step.
    Type: Application
    Filed: February 1, 2011
    Publication date: August 4, 2011
    Applicant: Enlighting, Inc.
    Inventors: Kung-Li Deng, Daniel R. Olson, Qing Ye
  • Electron-transporting materials and processes for making the same
    Patent number: 7989476
    Abstract: Compound of formula C is made by reacting a compound of formula A with an pyridyl boronic acid or pyridyl borate ester to form a compound of formula B; and combining the compound of formula B with a pyridyl dihalide to form the compound of C; wherein R3, R4, R5, R6 and R7 are, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; X is, independently at each occurrence, CH or N; Y is chloro or bromo; Z is bromo or iodo; and when Y is bromo, Z is iodo; d, e, and g are, independently at each occurrence, an integer ranging from 0-4; f is an integer ranging from 0-2; and h is an integer ranging from 0-3.
    Type: Grant
    Filed: January 8, 2009
    Date of Patent: August 2, 2011
    Assignee: General Electric Company
    Inventors: Kelly Scott Chichak, Qing Ye, Yangang Liang, Shengxia Liu, Rui Wang
  • ELECTRON-TRANSPORTING MATERIALS
    Publication number: 20110155955
    Abstract: Compounds of formula I may be used in optoelectronic devices wherein R1, R2 and R4 are, independently at each occurrence, H, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; R3 is H or a is, independently at each occurrence, 1 or 2; b is, independently at each occurrence, an integer ranging from 0-3; c is, independently at each occurrence, an integer ranging from 0-4; Ar is independently at each occurrence, H, or heteroaryl; and at least two of Ar are heteroaryl.
    Type: Application
    Filed: August 19, 2009
    Publication date: June 30, 2011
    Inventors: Qing Ye, Jie Liu, Kelly Scott Chichak, Yanggang Liang